Transdermal fentanyl: Informed prescribing is essential

European Journal of Pain

Volumn 7, Issue 5, 2003, Pages 481-483

  Ross, Joy R ^a   Quigley, Columba ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Cancer pain; Opioid toxicity; Transdermal fentanyl

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; CODEINE; FENTANYL; MORPHINE; MORPHINE SULFATE; MU OPIATE RECEPTOR AGONIST; NARCOTIC ANALGESIC AGENT; PARACETAMOL;

ADULT; AGED; ANALGESIA; ARTICLE; BACKACHE; CANCER PAIN; CANCER PATIENT; CASE REPORT; CHRONIC PAIN; CONTROLLED DRUG RELEASE; DROWSINESS; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; LUNG CARCINOMA; MALE; MULTIPLE MYELOMA; NAUSEA; PAIN; PATHOLOGIC FRACTURE; PATIENT EDUCATION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RIB FRACTURE; SUSTAINED RELEASE PREPARATION; THORAX PAIN; VERTIGO; VOMITING;

EID: 0042322430     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3801(02)00148-9     Document Type: Article

References (19)

1. Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained release oral morphine in cancer pain: preference, efficacy and quality of life. J Pain Symptom Manag 1997;13:254-61.
2. Allan L, Hays H, Jenson NHJ, de Waroux BL, Bolt M, Donald R, Kalso E. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001;322:1154-8.
3. Bohme K. Buprenorphine in a transdermal therapeutic system - a new option. Clin Rheumatol 2002;21(Suppl 1):S13-6.
4. Cherny NJ, Chang F, Frager G, Ingham JM, Tiseo PJ, Popp B, Portenoy RK, Foley KM. Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer 1995;76:1283-93.
5. Donner B. Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain 1996;64:527-34.
6. Donner B, Zenz M, Strumpf M, Raber M. Long-term treatment of cancer pain with transdermal fentanyl. J Pain Symptom Manage 1998;15:168-75.
7. Esteve M, Levron JC, Flaiser B, et al. Does aging modify pharmacokinetics of transdermal fentanyl. Br J Anaesth 1993;70(Suppl 1):S75 [abstract].
8. Gourlay GK. Treatment of cancer pain with transdermal fentanyl. Lancet Oncology 2001;2:165-72.
9. Grond S, Zech D, Lehman KA, Radbruch L, Breitenbach H, Hertel D. Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck origin. Pain 1997;69:191-8.
10. Grond S, Radbruch L, Lehmann KA. Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl. Clin Pharmacokinet 2000;38:59-89.
11. Hanks GW, Twycross RG, Lloyd JW. Unexpected complication of successful nerve block. Morphine-induced respiratory depression precipitated by removal of severe pain. Anaesthesia 1981;36:37-9.
12. Hanks GW, de Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Casas JR, Sawe J, Twycross RG, Ventafridda V. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 2001;84:587-93.
13. Hardy JR, Rees EAJ. A survey of transdermal fentanyl use in a major cancer center. J Pain Symptom Manag 1998;15:213-4.
14. Mercadante S. Is morphine the drug of choice in cancer pain?. Prog Pall Care 2001;9:190-3.
15. Mercadante S, Villari P. Clinical problems with transdermal fentanyl titration from 25 to 50 μgm/h. J Pain Symptom Manag 2001;21:448-9.
16. Muijsers RB, Wagstaff AJ. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs 2001;61:2289-307.
17. Radbruch L, Sabatowski R, Loick G, Kulbe C, Kasper M, Grond S, Lehmann KA. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med 2000;14:111-9.
18. Radbruch L, Sabatowski R, Petzke F, Brunsch-Radbruch A, Grond S, Lehmann KA. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients. Palliat Med 2001;15:309-21.
19. World Health Organisation. Cancer pain relief (ed 2). Geneva, Switzerland: World Health Organization, 1996.